HealthCor Management’s Novavax NVAX Stock Holding History

HealthCor Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-32,489	Closed	-$3.85M	–	72
2014 Q4	$3.85M	Buy	32,489 +2,989	+10%	+$312K	0.21%	42
2014 Q3	$2.46M	Buy	29,500 +9,500	+48%	+$859K	0.13%	44
2014 Q2	$1.85M	Sell	20,000 -35,812	-64%	-$3.15M	0.09%	50
2014 Q1	$5.06M	Sell	55,812 -174,188	-76%	-$19.5M	0.3%	48
2013 Q4	$23.6M	Buy	230,000 +55,100	+32%	+$3.89M	1.43%	26
2013 Q3	$11M	Buy	+174,900	New	+$9.85M	0.59%	40

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HealthCor Management's NVAX Position: Q1 2015 in Review

HealthCor Management sold out of Novavax (NVAX) in Q1 2015, closing a stake of 32,489 shares — an estimated $3.85M sold.

HealthCor Management first reported a position in NVAX in Q3 2013 and held it in 6 quarters. The position peaked at $23.6M in Q4 2013. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

HealthCor Management reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
HealthCor Management sold 32,489 Novavax shares in Q1 2015, an estimated $3.85M.
HealthCor Management first reported a position in Novavax in Q3 2013 and held it in 6 quarters.
HealthCor Management's Novavax position peaked at $23.6M in Q4 2013.
167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on HealthCor Management's 13F filing for Q1 2015, filed 15 May 2015.